BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced that the Company will hold 2021 R&D Day themed on �Science Drives Innovation in Beijing from 9:00 a.m. to 12:00 p.m. on April 15, 2021. InnoCare Management Team will share with the investors the latest development of the companys research and development, pre-clinical programs and clinical trials.
Investors who have interest can click the below link to submit participation information.
https://www.wjx.top/vj/exc203e.aspx
About InnoCare
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.
Contacts
Media
Chunhua Lu
86-10-66609879
chunhua.lu@innocarepharma.com
Investor Relations
86-10-66609999
ir@innocarepharma.com
Global leaders converge in Singapore to mark new era of growth and collaboration SINGAPORE -…
BANGKOK, THAILAND - Media OutReach Newswire - 25 November 2024 - Dr. Nalinee Paiboon, President…
Providing High-end Imaging Services: Establishing a New Benchmark for Personalized Medical Imaging Services HONG KONG…
JAKARTA, INDONESIA - Media OutReach Newswire - 22 November 2024 - VinFast Auto has officially…
SYDNEY, AUSTRALIA - Media OutReach Newswire - 22 November 2024 - The global cryptocurrency market…
HANOI, VIETNAM – Media OutReach Newswire - 22 November 2024 - By capitalizing on its…
